If you used Zantac or a generic ranitidine drug to manage heartburn and later received a cancer diagnosis or had other health issues, you may be eligible to file a Zantac lawsuit.
Current suits across the United States allege that Zantac contains high doses of a probable carcinogen, N-nitrosodimethylamine (NDMA).
To pursue a payout in this type of case, you will need to have evidence to show:
At Zanes Law, we can help you determine if you qualify to file a Zantac lawsuit. If so, you could recover compensation for your medical treatments, lost wages, pain and suffering, and more.
Contact Zanes Law for a free consultation on your case today. If we believe there is a link between your cancer and Zantac, we can represent you on a contingency-fee-basis. This means you pay us nothing upfront.
Once you and an attorney determine your eligibility to file a Zantac lawsuit, you will need to weigh your options for how to pursue damages. There are several options that may be available now or may become available soon. These include:
In an individual personal injury lawsuit, you will need to gather evidence to prove your case and take it to trial in your local courts. If you do not qualify for the multidistrict litigation (MDL) and suffered serious and unique damages as a result of a cancer diagnosis and treatment, this may be your best option. These cases may settle out of court during or before they go to trial, or they may proceed to a jury trial.
There is multidistrict litigation already underway against Zantac, according to the United States Judicial Panel on Multidistrict Litigation. Known as MDL 2924, this type of group lawsuit offers several advantages over pursuing a case as an individual.
An MDL allows you to share the costs and resources needed to handle pre-trial discovery and other pre-trial motions with the other plaintiffs in the case. This can be useful if expensive evidence such as expert testimony is required to link Zantac with your cancer.
In a report dated February 19, 2020, there were 140 pending cases already in MDL 2924. It is expected to grow due to the wide use of Zantac.
The case against Zantac and other affected ranitidine medications centers around the fact that the drug metabolizes in the body into a chemical known as N-nitrosodimethylamine (NDMA).
Although the United States Food and Drug Administration (FDA) has established a threshold for a safe daily limit of NDMA, lawsuits allege that the amount of NDMA released by Zantac exceeded this limit. Both over-the-counter and prescription formulas may be affected.
According to research by the Centers for Disease Control and Prevention, high doses of NDMA can cause liver and lung cancer in animals. They classify it as a probable human carcinogen.
The cases against Zantac include people who took the drug and developed cancer or other medical complications.
According to USA Today, Zantac is a popular medication that was prescribed up to 15 million times per year. Because of the large number of people who used this drug, it is possible that class-action lawsuit options may emerge against Zantac as well.
If you took Zantac or a related medication and were diagnosed with cancer, you may be eligible to participate in a lawsuit. You could recover compensation for your medical treatment, time missed at work, and other damages.
Call Zanes Law now at (866) 499-8989 for your free case evaluation with a member of our legal team. We can evaluate the strength of your case, explain your rights, and manage your case on your behalf.
Zanes Law operates on a contingency-fee-basis, meaning if we take on your case, you pay us nothing upfront. We only take payment as a percentage of your settlement or awards in court.